Original paper
Inhibition of CML Development Following Conditional SIRT1 Deletion in Transgenic BCR-ABL Mice
Abstract
Despite the success of tyrosine kinase inhibitors (TKIs) in treatment of CML, cures remain elusive, as primitive leukemia stem cells (LSC) are retained in patients achieving remission. Previous studies from our group have suggested that Sirtuin 1 (SIRT1) inhibition may represent a novel approach for elimination of LSCs in chronic phase CML. SIRT1 was shown to be overexpressed in CML LSCs, and SIRT1 inhibition using shRNA or a small molecule...
Paper Details
Title
Inhibition of CML Development Following Conditional SIRT1 Deletion in Transgenic BCR-ABL Mice
Published Date
Dec 2, 2016
Journal
Volume
128
Issue
22
Pages
931 - 931
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History